Alector, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alector, Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $14.70M.
- Alector, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $71.11M.
- Alector, Inc. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $224.51M, a 33.46% increase year-over-year.
- Alector, Inc. stock issued during period, value, new issues for the quarter ending 2019-03-31 was $168.22M.
- Alector, Inc. stock issued during period, value, new issues for fiscal 2025 was $19.98M, a 71.90% decline from fiscal 2024.
- Alector, Inc. stock issued during period, value, new issues for fiscal 2024 was $71.11M.
- Alector, Inc. stock issued during period, value, new issues for fiscal 2020 was $224.51M, a 33.46% increase from fiscal 2019.
- Alector, Inc. stock issued during period, value, new issues for fiscal 2019 was $168.22M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $19.98M 10-K · filed 2026-02-25 | |
| 2025-09-30 | $14.70M 10-Q · filed 2025-11-06 | |
| 2024-12-31 | $71.11M 10-K · filed 2026-02-25 | |
| 2024-03-31 | $71.11M 10-Q · filed 2025-11-06 | |
| 2020-12-31 | $224.51M 10-K · filed 2023-02-28 | |
| 2020-03-31 | $224.51M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $168.22M 10-K · filed 2022-02-24 | |
| 2019-03-31 | $168.22M 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |